The Problem: We Don’t Really Know! The problem with estimating the total cost burden of the autoimmune disease (AIID) epidemic is that we really don’t know! A May 2022 NIH report validates our long-held belief that missing and inconsistent data for autoimmune diseases (AIIDs) are at the root of the
“The first neurologist I went to see about my MS brushed off my questions and concerns about medications and made me feel helpless, as if no matter what lifestyle changes I made, MS would cripple me…” – anonymous patient participant in our “Autoimmunity Voices” survey Patient stories such as this
Vegetables have always been the vanguard to healthy eating. Seemingly since the dawn of time, parents have struggled to ensure their resistant children get enough greens. At least, until the point when they realize that eating these bland, sometimes bitter, leaves are actually a worthy sacrifice in the name of
About Us: Although digital health commands $4B in funding, autoimmune diseases have remained wallflowers at the party. So, how do we make this lonely world of autoimmune disease not so lonely? Currently, there is a huge unmet need in autoimmune disease. These not-obvious – under the surface – invisible –
An Overlooked Disease Autoimmune disease (AD) is a drastically underappreciated problem. There are 80-100 ADs, and researchers suspect that 40 additional diseases have an autoimmune element. AARDA estimates that 50 million Americans suffer from autoimmune disease, but there appears to be an increasing incidence in young adults. AD is responsible
Elaine Monarch suffered from a mysterious illness for most of her adult life. It was only in her 50s that she received an accurate diagnosis: celiac disease (CD). CD is an autoimmune disease that causes damage to the small intestine when a person eats gluten, a protein found in common